0001144204-17-009666.txt : 20170216 0001144204-17-009666.hdr.sgml : 20170216 20170216191530 ACCESSION NUMBER: 0001144204-17-009666 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170210 FILED AS OF DATE: 20170216 DATE AS OF CHANGE: 20170216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DERMA SCIENCES, INC. CENTRAL INDEX KEY: 0000892160 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232328753 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6095144744 MAIL ADDRESS: STREET 1: 214 CARNEGIE CENTER, SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DERMA SCIENCES INC DATE OF NAME CHANGE: 19940513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILLS STEPHEN T CENTRAL INDEX KEY: 0001103883 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13070 FILM NUMBER: 17619409 MAIL ADDRESS: STREET 1: PALATIN TECHNOLOGIES, INC. STREET 2: 4B CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 v459887_form4.xml FORM 4 X0306 4 2017-02-10 0 0000892160 DERMA SCIENCES, INC. DSCI 0001103883 WILLS STEPHEN T PALATIN TECHNOLOGIES, INC. 4C CEDAR BROOK DRIVE CRANBURY NJ 08512 1 0 0 1 Executive Chairman Common Stock 2017-02-10 4 M 0 4375 6.40 A 151076 D Common Stock 2017-02-10 4 F 0 4000 7.00 D 147076 D Stock Option (right to buy) 6.40 2017-02-10 4 M 0 4375 0 D 2007-03-01 2017-02-22 Common Stock 4375 0 D Shares delivered in connection with the cashless exercise of 4,375 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $6.40, as reported herein. A total of 35,000 of the options were granted pursuant to the issuer's stock option plan on March 1, 2007. Options for 25% of the shares vested immediately and options for the remaining shares vested at the rate of 25% per year starting on February 22, 2008.The revised total of 4,375 options reflects the issuer's 1-for-8 reverse split effective January 1, 2010. The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash. /s/ Stephen T. Wills 2017-02-16